1. Limouris GS. From the atomon of Democritus to the therapeutic nuclear medicine of today. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):S65–8.
2. Laverman P, Troost EGC, Philippens M, Lok JJ, Bussink J, Kaanders JHAM, et al. Correlation of [18F]FLT and [18F]FMISO autoradiography with immunohistochemistry in a series of human squamous cell carcinoma xenografts. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):S96–7.
3. Strauss LG, Klippel S, Schoenleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Accuracy of tumor detection based on quantitative PET data obtained in colorectal tumors. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):S120.
4. Dimitrakopoulou-Strauss A, Hoffmann M, Uppenkamp M, Haberkorn U, Strauss LG. Impact of full kinetic analysis of FDG follow-up studies in patients with non-small-cell-lung-cancer (NSCLC) receiving platin-based chemotherapy for prediction of therapy outcome. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):S199.
5. Strauss LG, Koczan D, Klippel S, Pan L, Burger C, Haberkorn U, et al. Impact of apoptosis on FDG kinetics. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):S153.